BACKGROUND: Assisted reproduction techniques can minimize the risk of infection and treat possible sterility associated with serodiscordant couples. METHODS: We assessed the efficacy of these techniques in 57 couples in which at least one partner had human immunodeficiency virus (HIV-1) infection that was currently under control (47 men and 10 women). The semen of seropositive men was prepared and tested for viruses. Assisted reproduction techniques included intrauterine insemination (IUI), IVF and especially ICSI, with ovarian stimulation that used a long agonist protocol and recombinant FSH. Embryos were transferred on day 3 after oocyte retrieval. RESULTS: For couples with seropositive men, five IUI and 49 IVF or ICSI attempts were perfomed, whilst for seropositive women these numbers were three IUI and 12 IVF or ICSI. No pregnancy occurred following the eight IUI trials. Seroconversion was not observed in any partners of seropositive men. Efficacy of treatment for these couples with ICSI was good, the clinical pregnancy rate per embryo transfer was 48.8%. The results for seropositive women were disappointing, with a clinical pregnancy rate per embryo transfer of 9.1%. Fourteen babies from 47 treated couples have so far been born and no pregnancies from IUI. CONCLUSIONS: Assisted reproduction techniques and particularly ICSI provide HIV-1-seropositive men with a safe and highly effective means of fathering children. These techniques may be less effective for seropositive women.
BACKGROUND: Assisted reproduction techniques can minimize the risk of infection and treat possible sterility associated with serodiscordant couples. METHODS: We assessed the efficacy of these techniques in 57 couples in which at least one partner had human immunodeficiency virus (HIV-1) infection that was currently under control (47 men and 10 women). The semen of seropositive men was prepared and tested for viruses. Assisted reproduction techniques included intrauterine insemination (IUI), IVF and especially ICSI, with ovarian stimulation that used a long agonist protocol and recombinant FSH. Embryos were transferred on day 3 after oocyte retrieval. RESULTS: For couples with seropositive men, five IUI and 49 IVF or ICSI attempts were perfomed, whilst for seropositive women these numbers were three IUI and 12 IVF or ICSI. No pregnancy occurred following the eight IUI trials. Seroconversion was not observed in any partners of seropositive men. Efficacy of treatment for these couples with ICSI was good, the clinical pregnancy rate per embryo transfer was 48.8%. The results for seropositive women were disappointing, with a clinical pregnancy rate per embryo transfer of 9.1%. Fourteen babies from 47 treated couples have so far been born and no pregnancies from IUI. CONCLUSIONS: Assisted reproduction techniques and particularly ICSI provide HIV-1-seropositivemen with a safe and highly effective means of fathering children. These techniques may be less effective for seropositive women.
Authors: Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer Journal: AIDS Date: 2010-01-16 Impact factor: 4.177
Authors: Rachelle J Chadwick; Joanne E Mantell; Jennifer Moodley; Jane Harries; Virginia Zweigenthal; Diane Cooper Journal: Top Antivir Med Date: 2011-11
Authors: Jolly Beyeza-Kashesya; Frank Kaharuza; Florence Mirembe; Stella Neema; Anna Mia Ekstrom; Asli Kulane Journal: Afr Health Sci Date: 2009-03 Impact factor: 0.927
Authors: Maryam Zafer; Hacsi Horvath; Okeoma Mmeje; Sheryl van der Poel; Augusto E Semprini; George Rutherford; Joelle Brown Journal: Fertil Steril Date: 2015-12-11 Impact factor: 7.329
Authors: G Carosi; P Nasta; S Fiore; A Matteelli; R Cauda; E Ferrazzi; E Tamburrini; V Savasi; T Bini; M Ravizza; A Bucceri; F Vichi; R Murri; F Mazzotta; A d'Arminio Monforte Journal: Infection Date: 2009-03-23 Impact factor: 7.455
Authors: Irene Molina; María Carmen Del Gonzalvo; Ana Clavero; Miguel Angel López-Ruz; Juan Mozas; Juan Pasquau; Antonio Sampedro; Luis Martínez; José Antonio Castilla Journal: Int J Fertil Steril Date: 2013-12-22